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Edited by Irmgard SinningAbstract It is believed that the membrane-proximal C tail of
the G protein-coupled receptors forms an additional alpha helix
with amphipathic properties (helix 8). It was previously shown
for the vasopressin V2 receptor (V2R) that a conserved dileucine
motif (L339, L340) in this putative helix 8 is necessary for endo-
plasmic reticulum (ER) to Golgi transfer of the receptor. Here,
we demonstrate that the other hydrophobic residues forming
the non-polar side of this helix (F328, V332 and L336) are also
transport-relevant. In contrast, the multiple serine residues con-
tributing to the more hydrophilic side (S330, S331, S333, S334,
S338) do not inﬂuence receptor traﬃcking. In addition, we show
unambiguously by the use of pharmacological chaperones that
the hydrophobic residues of the putative helix 8 do not form a
transport signal necessary for receptor sorting into ER to Golgi
vesicles. Instead, they are necessary to establish a transport-
competent folding state in the early secretory pathway.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Little is known concerning the transport of the G protein-
coupled receptors (GPCRs) via the intracellular membrane
systems to the cell surface. A crucial role for the membrane-
proximal C tail of GPCRs for intracellular traﬃcking has been
shown for the human vasopressin V2 receptor (V2R). A dileu-
cine motif in this receptor region (L339/L340) was essential for
eﬃcient ER to Golgi transport of the receptor [1]. Residue
E335, lying immediately N-terminal, was also transport-rele-
vant [1]. It was speculated that the dileucine motif and otherAbbreviations: AVP, arginine vasopressin; ER, endoplasmic reticulum;
GFP, green ﬂuorescent protein; GPCR, G protein-coupled receptor;
HEK 293 cells, human embryonic kidney cells; ICL, intracellular loop;
LSM, laser scanning microscopy; PAGE, polyacrylamide gel electro-
phoresis; PBS, phosphate buﬀered saline; SDS, sodium dodecyl sulfate;
TMH, transmembrane helix; V2R, human vasopressin V2 receptor
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doi:10.1016/j.febslet.2005.08.043conserved hydrophobic residues lying N-terminally (F328,
V332, L336) form a hydrophobic motif that is necessary for
transport-competent receptor folding in the ER in order to
pass the quality control system of this compartment that nor-
mally retains misfolded proteins (hxxxhxxhh motif, where h is
a hydrophobic residue and x can be any residue) [2]. However,
the signiﬁcance of F328, V332 and L336 for receptor folding and
transport has not been studied as yet.
Thereafter, similar motifs containing alternating hydropho-
bic residues were described for the membrane-proximal C tails
of other GPCRs. These motifs were necessary for ER to Golgi
transfer of the dopamine D1 receptor (FxxxFxxxF motif) [3],
the vasopressin V1b/V3 receptor (FNxxLLxxxL motif) [4], the
a2B adrenergic receptor and the angiotensin II type 1A receptor
(FxxxxxxxLL motif) [5]. The crystal structure of rhodopsin, the
archetypic GPCR, revealed that the membrane-proximal C tail
may form an additional a-helix with amphipathic properties
(helix 8) [6]. Hence, it was proposed that the hydrophobic resi-
dues of this domain form the hydrophobic side of helix 8 and
that this helix is necessary for ER to Golgi transfer of GPCRs
[3].
While it is well established that the hydrophobic residues of
the putative helix 8 are necessary for ER to Golgi transfer of
many GPCRs, it is a matter of debate whether these residues
represent a transport signal, necessary for sorting into ER to
Golgi vesicles or whether they are folding-relevant for the
receptors, in order to pass the quality control system of the
early secretory pathway. In the case of the D1 dopamine recep-
tor [3] and the V1b/V3 receptor [4] a sorting signal function
was proposed whereas for the V2R [2] and the A1 adenosine
receptor [7], a function in folding was described.
For the V2R, the transport relevance of the hydrophobic
residues lying N-terminal of the dileucine motif, forming the
non-polar side of the putative helix 8, has not been studied
as yet. Here, we ﬁrst show that these residues (F328, V332 and
L336) are also critical for receptor transport. The same holds
true for residue S329. In contrast, the other multiple serine res-
idues contributing to the more hydrophilic side of the putative
helix 8 (S330, S331, S333, S334, S338) do not inﬂuence receptor
traﬃcking. More importantly, we show unambiguously by
the use of pharmacological chaperones and truncated receptor
fragments that the hydrophobic residues of the membrane-
proximal C tail do not form a sorting signal but are relevant
for transport-competent receptor folding.blished by Elsevier B.V. All rights reserved.
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2.1. Materials
[3H] Arginine vasopressin (AVP; 2.4 tera Becquerel/mmol) was ob-
tained from Amersham Biosciences (Freiburg, Germany). Lipofect-
amine was purchased from Invitrogen (Leek, The Netherlands).
Restriction enzymes were from New England Biolabs (Schwalbach,
Germany). Coomassie blue was obtained from Serva (Heidelberg, Ger-
many). The Lumi-Light Western blotting substrate and the Lumi-
Imager F1 were from Roche Diagnostics (Mannheim, Germany).
Sulfo-NHS-Biotin and Immunopure Immobilized NeutrAvidin
were obtained from Pierce (Rockford, USA). Horseradish peroxi-
dase-conjugated a-rabbit IgG was purchased from Dianova (Ham-
burg, Germany). The polyclonal a-green ﬂuorescent protein (GFP)
serum was raised against a glutathione S-transferase/GFP-fusion pro-
tein in our group (unpublished results). Vectors pCDNA1.Neo and
pEGFP-N1 were from Invitrogen (Leek, The Netherlands) and Clon-
tech Laboratories (Heidelberg, Germany), respectively. The Quik-
Change site-directed mutagenesis kit was purchased from
Stratagene (La Jolla, USA). COS.M6 cells and HEK 293 cells were a
gift from F. Fahrenholz (Mainz, Germany). The V2R-selective antag-
onist SR121463B was kindly provided by C. Serradeil-Le Gal (Sanoﬁ
Synthelabo, Montpellier, France). All other reagents were obtained
from Sigma (Munich, Germany).
2.2. Plasmid constructions
Plasmid pRCDN2 [8], encoding the V2R cDNA in the vector pCD-
NAI.Neo was described. The mutations F328T, S329A, S330A,
S331A, V332A, S333A, S334A, L336T and S338A were introduced
using the QuikChange site-directed mutagenesis kit yielding plas-
mids pF328T, pS329A, pS330A, pS331A, pV332A, pS333A, pS334A,
pL336T and pS338A (untagged receptors; sequences of the oligonucle-
otides upon request). The corresponding GFP-tagged mutants were
constructed by cloning the EcoRI/HindIII fragments of these plasmids
into plasmid pWT.GFP cleaved with the same enzymes (pWT.GFP
encodes a C-terminally GFP-tagged V2R in the vector pEGFP-NI;
[2]). The resulting plasmids were pF328T.GFP, pS329A.GFP,
pS330A.GFP, pS331A.GFP, pV332A.GFP, pS333A.GFP,
pS334A.GFP, pL336T.GFP and pS338A.GFP. To construct the
GFP-tagged truncated receptor fragments containing the C-terminal
mutations, plasmid p71C/WT.GFP [2] was used. It encodes the ﬁrst
71 amino acids of the V2R followed by 41 wild-type C-terminal amino
acids of the membrane-proximal C tail (residues S327–K367) and a
C-terminally fused GFP moiety [2]. The single mutations F328T,
V332T and L336T as well as the combined mutations F328T/V332T/
L336T/L339T/L340T and F328A/V332A/L336A/L339A/L340A were
introduced into this plasmid using the QuickChange site-directed
mutagenesis kit (primer sequences upon request) yielding plasmids
p71C/F328T.GFP, p71C/V332T.GFP, p71C/L336T.GFP, p71C/
FVLLL-T.GFP and p71C/FVLLL-A.GFP, respectively. Plasmid
pL339/340T.GFP, encoding the full-length GFP-tagged V2R with a
mutant dileucine motif and the corresponding mutant truncated recep-
tor fragment p71C/L339/340T.GFP have been described [1,2]. Plasmid
L62P.GFP, encoding a V2R mutant that could not be rescued by treat-
ment with pharmacological chaperones has also been described [2].2.3. Cell culture
HEK 293 cells and COS.M6 cells were grown in Dulbeccos modiﬁed
Eagles medium supplemented with 10% heat-inactivated fetal calf ser-
um, 100 international units/ml penicillin and 100 lg/ml streptomycin.
Cells were cultivated at 37 C in a humidiﬁed atmosphere containing
5% CO2.2.4. Visualization of GFP-tagged full-length receptors and truncated
receptor fragments
4 · 104 HEK 293 cells in a 35 mm diameter dish containing a poly-L-
lysine (MW 300000) coated coverslip were transfected with 500 ng
plasmid DNA and 7.5 ll lipofectamin according to the suppliers rec-
ommendations. Cells were incubated for 16 h after transfection,
washed twice with phosphate buﬀered saline (PBS) and then trans-
ferred immediately into a self-made chamber [9]. Cells were covered
with 1 ml PBS and GFP ﬂuorescence was visualized on a Zeiss 510 in-
vert laser scanning microscope (kexc = 488 nm, kem > 515 nm).2.5. Cell surface biotinylation assay and immunoblot
9 · 105 stably transfected HEK 293 cells were grown for 48 h in a
60 mm diameter dish to 80% conﬂuence. The cell surface biotinyla-
tion assay and precipitation of biotinylated proteins was carried out
in the cold with sulfo-NHS-Biotin and NeutrAvidinTM as described
previously [10]. Biotinylated proteins were separated by sodium
dodecyl sulfate–polyacrylamide gel electrophoresis (SDS–PAGE)
(10% acrylamide) and blotted onto nitrocellulose as described [11].
Membranes were blocked for 1 h with blot buﬀer [20 mM Tris–Cl,
0,15 mM NaCl, 1% (w/v) Triton X-100, 5% (w/v) lot fat milk pow-
der; pH 7.5]. The polyclonal anti-GFP antiserum (1:1000) was added
and membranes were incubated for 1 h at room temperature. Filters
were washed three times (15 min each) with blot buﬀer without milk
powder. Thereafter, ﬁlters were incubated with horseradish peroxi-
dase-conjugated anti-rabbit IgG (1:5000 in blot buﬀer) for 1 h at
room temperature. Filters were washed three times (10 min each)
with blot buﬀer, twice with blot buﬀer without milk powder, and
once (10 min) with 10 mM Tris–Cl (pH 7.5). Finally, the ﬁlters were
incubated in the Lumi-Light Western blotting substrate solution,
and the enhanced chemiluminescence signals were recorded by using
the Lumi-Imager F1.
2.6. Incubation of cells with the non-peptide V2R antagonist SR121463B
4 · 104 HEK 293 cells in a 35 mm diameters dish containing a poly-
L-lysine (MW 300000) coated coverslip were transfected with 500 ng
plasmid DNA and 7.5 ll lipofectamin according to the suppliers rec-
ommendations. Treatment of cells with SR121463B was carried out
essentially as described previously [12]. Brieﬂy, cells were incubated
6 h after transfection with 1 lM SR121463B and incubated for another
16 h. Coverslips with cells were washed twice with PBS and the GFP
ﬂuorescence of the receptors were analyzed by confocal laser scanning
microscopy (LSM) as described above.2.7. Molecular modelling of the V2R
The structure model of the V2R is based on the rhodopsin structure
[6]. Model assembly has been described previously [2,12,13]. The start-
ing complex was minimized using an AMBER 5.0 force ﬁeld [14] and
molecular dynamics simulations were performed at 300 K for 500 ps.
Only hydrogen bonds of the transmembrane helix (TMH) backbones
maintaining the helices were restrained. Low energy conformations
of at least 50 ps were compared. The quality and stability of the model
was validated by checking the geometry with PROCHECK [15].
2.8. Miscellaneous
The [3H] AVP binding assay with transiently transfected COS.M6
cells was described previously [8]. Standard DNA preparations and
manipulations were carried out. The nucleotide sequences of DNA
fragments were veriﬁed by sequencing, using the FS Dye Terminator
kit from Perkin–Elmer (Weiterstadt, Germany).3. Results
3.1. Construction of mutant V2Rs
The signiﬁcance of the dileucine motif (L339/L340; Fig. 1A) in
the membrane-proximal C tail of the V2R for ER exit was
described previously (L339/340T double mutant) [1]. To adress
the question whether the other hydrophobic residues, namely
F329, V332 and L336 contribute to a larger hydrophobic se-
quence motif, these residues were also replaced by threonine
residues yielding mutants F328T, V332T and L336T
(Fig. 1A). To enable the intracellular localization of the mu-
tant receptors by confocal LSM, C-terminal GFP tags were
added (we have previously shown that the GFP tag has no
inﬂuence upon receptor function and traﬃcking [1,2]). To
study the transport relevance of the multiple serine residues
in this receptor region, alanine substitutions were constructed
yielding mutants S329A, S330A, S331A, S333A, S334A and
S338A (Fig. 1A). GFP tags were also added in this case. In
Fig. 1. (A) Topological model of the human V2R and construction of receptor mutants. The one-letter code for amino acids is used. The following
putative post-translational modiﬁcations are shown in the model (upper panel): glycosylation at N22, palmitoylation at C341 and C342 and a disulﬁde
bond between C112 and C192. The amino acid replacements in the membrane proximal C tail are shown in the lower panel. Hydrophobic amino acid
residues are depicted by open rectangles. (B) Characterization of the wild-type V2R by confocal LSM. Transiently transfected HEK 293 cells
expressing the GFP-tagged receptor were analyzed by confocal LSM with horizontal xy and vertical z scans. The z scan was carried out at the
indicated line. The GFP ﬂuorescence signals of the receptor are shown in representative cells. Scale bar, 25 lm. Similar data were obtained in ﬁve
independent experiments. (C) Characterization of the wild-type V2R by a [3H] AVP binding experiment. Speciﬁc [3H] AVP binding of intact,
transiently transfected COS.M6 cells expressing the untagged receptor. Data represent mean values of duplicates which diﬀered by less than 10%. In
all binding experiments, unspeciﬁc binding contributed up to 30% of total binding. The results are representative of three individual experiments.
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(Fig. 1A) was used as a control.
3.2. The hydrophobic residues of the membrane-proximal C tail
of the V2R form a transport-relevant sequence motif
Traﬃcking of the mutant receptors to the plasma membrane
was assessed in this study by localising the ﬂuorescence signals
of the GFP-tagged receptors in living, transiently transfectedHEK 293 cells by confocal LSM. All imaging results were ver-
iﬁed by recording [3H] AVP binding proﬁles to intact COS.M6
cells expressing the untagged receptors. We assumed that
mutation of the C-terminal cytoplasmic loop would not inter-
fere with the hormone binding site and that ligand binding to
intact cells would thus correlate with receptor transport to the
plasma membrane. COS.M6 cells were used instead of HEK
293 cells in the binding experiments because they are more
5230 A. Thielen et al. / FEBS Letters 579 (2005) 5227–5235adherent and thus facilitate washing procedures. Typical re-
sults obtained for the wild-type control by this experimental
setup are shown in Fig. 1B and C. Confocal LSM revealed
the predominant expression of the wild-type receptor at the cell
surface in both horizontal xy scans and vertical z scans
(Fig. 1B). Additional GFP signals were located inside the cells,Fig. 2. Mutants of the serine residues of the membrane-proximal C tail: confo
transfected HEK 293 cells expressing the GFP-tagged receptor mutants S
S338A.GFP were analyzed by confocal LSM with xy scans. The GFP ﬂuoresc
data were obtained in ﬁve independent experiments. Central panels. The same
[3H] AVP binding of intact, transiently transfected COS.M6 cells expressin
control experiment with the wild-type receptor was performed in parallel a
represent mean values of duplicates which diﬀered by less than 10%. In all b
binding. The results are representative of three individual experiments.presumably representing transport intermediates en route to
the cell surface or receptors which are abundant as a conse-
quence of overexpression. The [3H] AVP binding assay
(Fig. 1C) yielded a typical binding curve with a KD value of
3.4 nM. The results obtained for the wild-type control are in
good agreement with previous reports [1,2].cal LSM and [3H] AVP binding experiments. Upper panels. Transiently
329A.GFP, S330A.GFP, S331A.GFP, S333A.GFP, S334A.GFP and
ence signals of representative cells are shown. Scale bar, 25 lm. Similar
cells were analyzed by z scans at indicated lines. Lower panels. Speciﬁc
g the corresponding untagged receptor mutants. For each mutant, a
nd the results are expressed as percentage of wild-type binding. Data
inding experiments, unspeciﬁc binding contributed up to 30% of total
Fig. 3. Mutants of the hydrophobic residues of the membrane-
proximal C tail: confocal LSM and [3H] AVP binding experiments.
Upper panels. Transiently transfected HEK 293 cells expressing the
GFP-tagged receptor mutants F328T.GFP, V332T.GFP, L336T.GFP
and L339/340T.GFP were analyzed by confocal LSM with xy scans.
The GFP ﬂuorescence signals of representative cells are shown. Scale
bar, 25 lm. Similar data were obtained in ﬁve independent experi-
ments. Central panels. The same cells were analyzed by z scans at the
indicated lines. Lower panels. Speciﬁc [3H] AVP binding of intact,
transiently transfected COS.M6 cells expressing the corresponding
untagged receptor mutants. For each mutant, a control experiment
with the wild-type receptor was performed in parallel and the results
are expressed as percentage of wild-type binding. Data represent mean
values of duplicates which diﬀered by less than 10%. In all binding
experiments, unspeciﬁc binding contributed up to 30% of total binding.
The results are representative of three individual experiments.
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(Fig. 2). In the case of mutants S330A, S331A, S333A,
S334A and S338A, similar results were obtained as described
for the wild-type receptor. The GFP ﬂuorescence signals were
detectable at the plasma membrane (upper and central panels
for each mutant) and the binding curves (lower panels for each
mutant) overlapped largely with those of the wild-type con-
trols performed in parallel for each of the mutants (KD values:
S330A = 7.2 nM, S331A = 2.6 nM, S333A = 1.8 nM; S334A =
1.4 nM; S338A = 4.2 nM). These serine residues thus do not
inﬂuence traﬃcking of the V2R. In the case of mutant
S329A, however, expression at the plasma membrane was
hardly detectable and strong intracellular GFP signals were
found. Consistently, maximal [3H] AVP binding of this mutant
was reduced (Bmax = 29% of the wild-type; KD value = 2.6 nM)
demonstrating that residue S329 is necessary for eﬃcient recep-
tor transport to the plasma membrane.
In contrast to most of the serine substitutions, replacement of
the hydrophobic residues of themembrane-proximalC tail hada
strong inﬂuence upon receptor transport (Fig. 3). In the case of
the mutants F328T and L336T and the previously described
mutant L339/340T [1], only intracellular GFP signals were
detectable using confocal LSM (upper and central panels for
each mutant). The GFP ﬂuorescence signals ﬁlled diﬀusely the
cells interior except of the nucleus. Maximal [3H] AVP binding
was consistently strongly reduced indicating that these residues
are essential for eﬃcient receptor transport (F328T, Bmax = 9%
of the WT; KD = 3.4 nM; L336T, Bmax = 11% of the WT, KD =
2.21 nM; L339/340T = complete binding defect). The receptors
responsible for the residual binding in the case of mutants
F328T and L336T are obviously not detectable by confocal
LSM. Among the mutants of the hydrophobic residues, the
mutant V332T displayed a weaker transport defect indicated
by only a decrease in the detectable plasmamembraneGFPﬂuo-
rescence and a roughly halved maximal [3H] AVP binding
(Bmax = 46% of the WT; KD = 2.1 nM).
We have also assessed the glycosylation state of the GFP-
tagged mutants to conﬁrm that the intracellular portion of
the mutant receptors is retained in the early secretory pathway,
as previously shown for the mutant of the dileucine motif
L339/340T [1]. In the case of the almost completely trans-
port-defective mutants F328T and L336T, only the high man-
nose forms were detectable (data not shown). These data are
consistent with a retention of the mutants in the early secretory
pathway in agreement with the results obtained for the mutant
of the dileucine motif [1].
In summary the data above show that the hydrophobic res-
idues in the membrane-proximal C tail form a motif that is
necessary for eﬃcient V2R transport. Among the multiple
serine residues in this receptor domain, only S329 is transport-
relevant.
3.3. The hydrophobic residues in the membrane-proximal C tail
of the V2R do not form a transport signal
The sequence motif may represent a transport signal which is
recognised by a component of ER to Golgi vesicles. Alterna-
tively, it may be necessary for transport-competent receptor
folding to pass the quality control system of the early secretory
pathway. To assess these two possibilities we used a receptor
fragment allowing transport studies independent of full-length
receptor folding [2]. In this construct, transmembrane domains
II-VII of the V2R are deleted, thereby fusing the intracellularC-terminus to the ﬁrst cytoplasmic loop (Fig. 4A, 71C/
WT.GFP) [2]. To allow intracellular localization, this con-
struct is C-terminally GFP-tagged. The mutations of the
Fig. 4. Mutants of the hydrophobic residues of the membrane-proximal C tail: localization of GFP-tagged V2R fragments in transiently transfected
HEK 293 cells. (A) The GFP ﬂuorescence signals of cells expressing the receptor fragments 71C/WT.GFP (control), 71C/F328T.GFP, 71C/
V332T.GFP, 71C/L336T.GFP and 71C/L339/340T.GFP were analyzed by confocal LSM with xy scans (upper panels) and with z scans (lower
panels) at the indicated lines. The scans show representative cells. Scale bar, 25 lm. The results are representative of three individual experiments.
(B) The GFP ﬂuorescence signals of cells expressing the mutant receptor fragments 71C/FVLLL-A.GFP and 71C/FVLLL-T.GFP (combined
mutations) were analyzed as described in (A). The scans show representative cells. Scale bar, 25 lm. The results are representative of two individual
experiments. (C) Cell surface biotinylation experiment. The cell surface proteins of transiently transfected HEK293 cells expressing the mutant
receptor fragments shown in (B) were labeled with biotin, isolated with neutravidin and the constructs reaching the plasma membrane were detected
by immunoblotting using an anti-GFP-antiserum. The results are representative of two individual experiments.
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receptor (F328T, V332T, L336T, L339/340T) were introduced
into this receptor fragment yielding constructs 71C/
F328T.GFP, 71C/V332T.GFP, 71C/L336T.GFP and 71C/
L339/340T.GFP. If the hydrophobic residues contribute to a
sorting signal, mutants should be transport-deﬁcient in this
system, too. If they are, however, essential for folding of the
full-length receptor, transport should be retained [2].
Transport of the constructs was assessed in transiently trans-
fected HEK 293 cells by confocal LSM (Fig. 4A). For all four
mutant receptor fragments, GFP ﬂuorescence signals at the
plasma membrane could be detected in similar amounts as
for the control construct containing the wild-type C tail
(71C/WT.GFP). These data suggest that the motif is folding-
relevant. To conﬁrm these results, we also exchanged all
hydrophobic residues (F328, V332, L336, L339, L340) in combina-
tion either by threonine or alanine residues (constructs
CT.FVLLL-A.GFP and CT.FVLLL-T, respectively). Again,
GFP ﬂuorescence signals at the plasma membrane were detect-
able (Fig. 4B). These results were further conﬁrmed by cell sur-face biotinylation experiments (Fig. 4C): plasma membrane
proteins of transiently transfected HEK 293 cells were labeled
with biotin, isolated with neutravidin and the receptor frag-
ments reaching the plasma membrane were speciﬁcally de-
tected by immunoblotting using antibodies directed against
their GFP moieties. Again, all constructs were detectable as
a 60 kDa protein band in similar amounts at the cell surface.
To demonstrate unambiguously that the hydrophobic resi-
dues of the membrane-proximal C tail are folding-relevant,
we used pharmacological chaperones. It was shown previously
that membrane-permeable V2R antagonists such as
SR121463B are able to rescue transport-defective V2R mu-
tants [16]. These antagonists bind to the receptors in the ER
and favor correct folding of the receptors thereby allowing
them to pass the quality control system of the early secretory
pathway [12]. Transiently transfected HEK 293 cells expressing
the V2R mutants F328T.GFP, V332T.GFP, L336T.GFP and
L339/340T were treated with the antagonist SR121463B and
cells were analyzed by confocal LSM (Fig. 5). As a negative
control, we used the L62P mutant that could not be rescued
Fig. 5. Mutants of the hydrophobic residues of the membrane-
proximal C tail: restoration of cell surface expression by pharmaco-
logical chaperone treatment. Transiently transfected HEK 293 cells
expressing the GFP-tagged receptor mutants F328T.GFP,
V332T.GFP, L336T.GFP and L339/340T.GFP were incubated with
the V2R antagonist SR121463B (1 lM) for 16 h or left untreated
(control). The GFP ﬂuorescence signals of the receptors were analyzed
by confocal LSM with xy scans. The scans show representative cells.
As a negative control, the L62P mutant was used. This mutant could
not be rescued by SR121463B treatment in a previous study [12]. Scale
bar, 25 lm. The results are representative of three individual exper-
iments.
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the receptors GFP ﬂuorescence signals to the cell surface was
observed for each of the mutants of the hydrophobic residues
of the membrane-proximal C tail proving that these mutants
have been misfolded before pharmacological chaperone
treatment.
3.4. Homology model of the V2R
If the hydrophobic residues of the membrane-proximal C
tail of the V2R are required for folding, this should be re-
ﬂected in the conformation of the motif-bearing region and
in its interactions within the receptor molecule. To addressthis question, a homology model of the V2R was computed.
The model is based on the 3D structure of rhodopsin and
was reﬁned by molecular dynamics simulations. The model
(Fig. 6) revealed that the membrane-proximal C tail of the
V2R may form a similar amphipathic a-helix as reported pre-
viously for rhodopsin (helix 8) [6]. In the case of the V2R,
residues V332, L336 and the dileucine motif L339/L340 may
form the hydrophobic side of the putative helix 8 which could
interact with hydrophobic residues of TMH1 and the TMH1/
ICL1 interface (L53, L57, V58, A61, and L62). Residue F328
may interact with I74 of TMH2 and M272 of TMH6 whereas
S329 may form an H-bond towards the backbone carboxy
oxygen of Y325 of TMH7.4. Discussion
We report here that the hydrophobic residues F328, V332 and
L336 of the membrane-proximal C tail of the V2R are trans-
port-relevant. The same holds true for residue S329 and the pre-
viously published dileucine motif (L339/L340) in this receptor
region [1]. We could also show here that the other multiple ser-
ine residues of the membrane-proximal C tail ( S330, S331, S333,
S334, S338) have no inﬂuence upon receptor traﬃcking.
Our structure model predicts that residues V332, L336 and the
dileucine motif L339/L340 form the hydrophobic side of an
amphipathic helix (helix 8) interacting with hydrophobic resi-
dues of TMH1 and the TMH1/ICL1 interface (L53, L57, V58,
A61, and L62). These C-terminal residues would thus be
important structural determinants, necessary for long range
interactions within the receptor molecule connecting N- and
C-terminal receptor portions. Residues F328 may also partici-
pate in such long range interactions by binding to I74 of
TMH2 and M272 of TMH6. Residue S329, in contrast, may
inﬂuence receptor folding more locally and stabilise by its
binding to the backbone of Y325the last helical turn of
TMH7 and the TMH7/helix 8 junction. In summary the model
readily explains the result that mutation of residues F328, S329,
V332, L336 and L339/L340 causes misfolding and consequently a
transport defect. The model also explains very well why the
other multiple serine residues (S330, S331, S333, S334, S338) are
not transport relevant: these residues form the polar side of
the putative helix 8 which is predicted not contribute to intra-
molecular interactions.
An uncertainty associated with the model interpretation
above is that our model basis, the 3D structure of rhodopsin,
was resolved using crystals of completely folded and functional
protein. It is unclear whether the membrane-proximal C tail of
rhodopsin or that of the V2R adopts a helical conformation in
the early secretory pathway. Growing evidence indicates that
the membrane-proximal C tail of GPCRs only forms a helix
if membrane lipids are present while it is disordered and exhib-
its a random coiled conformation in an aqueous medium
[17–19]. It was proposed that the conformation of the mem-
brane-proximal C tail may even change in the receptor and that
it acts as amembrane-dependent conformational switch domain
[20]. Thus, it can not be excluded at the moment that the mem-
brane-proximal C tail of the V2R is non-helical in the early
secretory pathway. In the latter case, it may form a loop struc-
ture, its hydrophobic residues also interacting with the TMH1/
ICL1 interface [2]. Although all available data are consistent
Fig. 6. Detail of a homology model of the V2R. The model was calculated using the three-dimensional structure of bovine rhodopsin as a template.
Portions of TMH1, TMH2, TMH6, TMH7 and ICL1 are indicated. The membrane-proximal C tail forms an amphipathic helix (helix 8). The
hydrophobic residues V332, L336 and the dileucine motif L339/L340 interact with hydrophic residues of TMH1 and the TMH1/ICL1 interface (L53, L57,
V58, A61, L62). Residue F328 interacts with I74 of TMH2 and M272 of TMH6. S329 forms a H-bond towards the backbone carboxy oxygen of Y325 of
TMH7 stabilising the last turn of TMH7 and the TMH7/helix 8 junction.
5234 A. Thielen et al. / FEBS Letters 579 (2005) 5227–5235with a helical conformation, additional experiments will be
needed to verify such a helical model.
Conﬂicting data were published whether hydrophobic motifs
in the membrane-proximal C tails of other GPCRS represent
transport signals, necessary for sorting into ER to Golgi vesi-
cles, e.g., [3,4] or whether they are folding-relevant, necessary
to pass the quality control system of the early secretory path-
way, e.g., [2,7]. We show here by the use of truncated receptor
fragments and by treatment of full-length receptors with phar-
macological chaperones that the domain of the V2R is indeed
folding-relevant. While it is possible that diﬀerent motifs may
serve diﬀerent functions, experiments using pharmacological
chaperones seem to be a useful tool in the future to distinguish
also for the other GPCRs between sorting signals and folding-
relevant domains. Such substances may promote by their bind-
ing correct receptor folding and a rescue of a given receptor
mutant would demonstrate that the mutant was misfolded be-
fore treatment.
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